Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study – results of the Belgian subgroup
Objective: The primary objective of the study was to evaluate the proportion of Parkinson’s Disease (PD) patients in Movement Disorder Centers with Advanced Parkinson’s Disease…Impact of globus pallidus interna deep brain stimulation on REM sleep behavior disorder in Parkinson’s disease
Objective: The aim of this study was to determine if there is an improvement in rapid eye movement (REM) sleep behavior disorder (RBD) for patients…Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients
Objective: This systematic review aims mainly to investigate pain as an independent risk factor for developing depressive symptoms among patients with PD. Background: Parkinson's disease…Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report
Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…Deep brain stimulation for movement disorders: Assessing disparities in access to care
Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease
Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…Assessing the swallow tail sign in clinical practice
Objective: To evaluate the swallow tail sign accuracy to distinguish between essential tremor (ET) and Parkinson’s disease (PD) in clinical practice. Background: The swallow tail…How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial
Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…A validation study of the Mini-BESTest in a Spanish population with Parkinson’s disease.
Objective: Because the Mini Balance Evaluation Systems Test (Mini-BESTest) is widely used, our aim was to validate the Spanish version in PD. Background: Parkinson's disease…The Effects of Motor Imagery Therapy in the rehabilitation of patients with Parkinson’s Disease: A Systematic Review
Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with Motor Imagery Therapy. Background: Parkinson's disease (PD) is one of the most…
- « Previous Page
- 1
- …
- 209
- 210
- 211
- 212
- 213
- …
- 436
- Next Page »